Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 15, 2026

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets
03:37

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets

Published on: March 1, 2024

Multimodal interpretable deep learning for transcriptome-informed precision oncology and drug mechanism analysis.

Ning Qu1,2, Xiaochu Tong1,2, Zhaokun Wang1,2

  • 1Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai, China.

NPJ Digital Medicine
|May 13, 2026
PubMed

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intravenous lipid emulsion improves recovery time and quality from isoflurane anaesthesia: a double-blind clinical trial.

Basic & clinical pharmacology & toxicology·2014
Same author

Improvement of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for identification of clinically important Candida species.

Clinical laboratory·2014
Same author

Genetic engineering of the green alga Chlorella zofingiensis: a modified norflurazon-resistant phytoene desaturase gene as a dominant selectable marker.

Applied microbiology and biotechnology·2014
Same author

Successful one-stage extraction of an intracardiac and intravenous leiomyoma through the right atrium under transesophageal ultrasound monitoring.

Canadian journal of anaesthesia = Journal canadien d'anesthesie·2014
Same author

A particle swarm optimization variant with an inner variable learning strategy.

TheScientificWorldJournal·2014
Same author

Integrative Analysis of Cancer Diagnosis Studies with Composite Penalization.

Scandinavian journal of statistics, theory and applications·2014
Summary

BioGDR, a new deep learning framework, enhances precision oncology by predicting drug responses using integrated biological data. It offers mechanistic insights and outperforms existing methods in drug discovery and clinical applications.

Area of Science:

  • Computational biology
  • Bioinformatics
  • Machine learning in oncology

Background:

  • Precision oncology requires interpreting complex cellular signals for predicting drug responses in diverse cancer types.
  • Current methods often lack the ability to integrate multimodal data for comprehensive analysis.

Purpose of the Study:

  • To introduce BioGDR, a multimodal interpretable deep learning framework for precision oncology.
  • To enable mechanistic insights into drug sensitivity by integrating biological features without experimental measurements.

Main Methods:

  • Utilized pathway-informed graph neural networks to model tumor transcriptomic states.
  • Employed a drug-guided attention strategy for multimodal data integration.
  • Integrated structure-based predicted biological features like differential gene expression and kinase inhibition profiles.

Related Experiment Videos

Last Updated: May 15, 2026

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets
03:37

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets

Published on: March 1, 2024

Main Results:

  • BioGDR demonstrated superior performance in compound screening for early-stage drug discovery.
  • Achieved high accuracy in predicting cell line sensitivity across heterogeneous cellular states.
  • Clinical patient cohort analyses confirmed BioGDR's practical utility and generalization capability.
  • Experimental validation identified sensitive cell populations and elucidated mechanisms for a novel ALDH1B1 inhibitor.

Conclusions:

  • BioGDR provides a robust, biologically informed framework for advancing precision oncology.
  • The framework effectively bridges preclinical drug development and clinical applications.
  • Integrative, multimodal learning and interpretable mechanism analysis are key to BioGDR's success.